Cerity Partners’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $433K | Sell |
46,532
-5,527
| -11% | -$51.4K | ﹤0.01% | 1945 |
|
|
2025
Q1 | $350K | Sell |
52,059
-619
| -1% | -$4.17K | ﹤0.01% | 1937 |
|
|
2024
Q4 | $663K | Sell |
52,678
-425
| -0.8% | -$5.35K | ﹤0.01% | 1610 |
|
|
2024
Q3 | $776K | Buy |
53,103
+5,043
| +10% | +$73.7K | ﹤0.01% | 1532 |
|
|
2024
Q2 | $582K | Sell |
48,060
-31,163
| -39% | -$377K | ﹤0.01% | 1472 |
|
|
2024
Q1 | $1.96M | Buy |
79,223
+17,877
| +29% | +$441K | 0.01% | 981 |
|
|
2023
Q4 | $656K | Buy |
+61,346
| New | +$656K | ﹤0.01% | 1151 |
|
|
2023
Q3 | – | Sell |
-67,126
| Closed | -$531K | – | 1543 |
|
|
2023
Q2 | $531K | Buy |
67,126
+13,779
| +26% | +$109K | ﹤0.01% | 1151 |
|
|
2023
Q1 | $266K | Hold |
53,347
| – | – | ﹤0.01% | 1588 |
|
|
2022
Q4 | $118K | Sell |
53,347
-3,615
| -6% | -$7.99K | ﹤0.01% | 1398 |
|
|
2022
Q3 | $253K | Hold |
56,962
| – | – | ﹤0.01% | 965 |
|
|
2022
Q2 | $183K | Sell |
56,962
-36,584
| -39% | -$118K | ﹤0.01% | 1087 |
|
|
2022
Q1 | $531K | Sell |
93,546
-1,180
| -1% | -$6.7K | 0.01% | 579 |
|
|
2021
Q4 | $1.23M | Sell |
94,726
-7,278
| -7% | -$94.4K | 0.02% | 403 |
|
|
2021
Q3 | $2.48M | Sell |
102,004
-2,485
| -2% | -$60.5K | 0.05% | 237 |
|
|
2021
Q2 | $1.81M | Sell |
104,489
-5,838
| -5% | -$101K | 0.04% | 279 |
|
|
2021
Q1 | $3.74M | Sell |
110,327
-12,219
| -10% | -$414K | 0.09% | 174 |
|
|
2020
Q4 | $1.19M | Buy |
+122,546
| New | +$1.19M | 0.04% | 284 |
|